Table 1.
Baseline demographic data.
| Variables | All Patients (n = 292) | |||
|---|---|---|---|---|
| Group 1 Proximal Radial or Transvenous Access (n = 235) |
Group 2 Distal Radial Access (n = 57) |
p-Value | ||
| Age (years) | 66.7 (±11.5) | 66.7 (±11.5) | 66.7 (±11.6) | 0.916 |
| Sex (F/M) | 110 (37.7%)/182 (62.3%) | 89 (37.9%)/146 (62.1%) | 21 (36.8%)/36 (63.2%) | 0.885 |
| Hypertension | 163 (55.8%) | 133 (56.6%) | 30 (52.6%) | 0.589 |
| Cerebrovascular disease | 80 (27.4%) | 68 (28.9%) | 12 (21.1%) | 0.231 |
| Coronary artery disease | 117 (40.1%) | 96 (40.9%) | 21 (36.8%) | 0.580 |
| Smoking history | 195 (66.8%) | 160 (68.1%) | 35 (61.4%) | 0.337 |
| Current smoker | 121 (41.4%) | 97 (41.3%) | 24 (42.1%) | 0.909 |
| Diabetes | 132 (45.2%) | 108 (46%) | 24 (42.1%) | 0.600 |
| Hyperlipidemia | 183 (62.7%) | 144 (61.3%) | 39 (68.4%) | 0.317 |
| INR | 1.34 (±0.3) | 1.35 (±0.3) | 1.32 (±0.3) | 0.446 |
| aPTT (s) | 39 (±5.7) | 39.1 (±5.7) | 38.7 (±5.9) | 0.762 |
| Platelet count (No. ×103/μL) | 333.6 (±127.5) | 328.8 (±128.3) | 353.3 (±123.2) | 0.087 |
| Coagulopathy | 119 (40.8%) | 92 (39.1%) | 27 (47.4%) | 0.257 |
| Antiplatelet therapy | 154 (52.7%) | 124 (52.8%) | 30 (52.6%) | 0.985 |
| Anticoagulant therapy | 134 (45.9%) | 110 (46.8%) | 24 (42.1%) | 0.523 |
Abbreviations: μL: microliter; aPTT: activated partial thromboplastin time; F: female; INR: international normalized ratio; M: male; s: seconds.